Geropharm-Bio

Geropharm is a leading Russian biotechnology company specializing in the full-cycle production of insulin and other essential biopharmaceuticals. The company is recognized for its extensive portfolio of diabetes treatments, including human insulins and analogues such as RinSulin, RinGlar, and RinFast. In addition to endocrinology, Geropharm develops and manufactures proprietary drugs for neurology and ophthalmology, most notably Cortexin and Retinalamin. Operating high-tech manufacturing sites in St. Petersburg and Obolensk, the company adheres to international GMP standards and exports its products to numerous international markets. Geropharm's R&D center focuses on the development of biosimilars and original drugs to address unmet medical needs in chronic diseases.